call for expressions of interest: women’s economic empowerment in a low-carbon covid-19 recovery

eligibility: 
  • this call is open to institutions with legal corporate registration, and with demonstrable capacity to manage and undertake the proposed work, including:
    • the ability to implement, monitor, and report on research grants from international funders
    • the ability and procedures to assess and manage project, organizational, and funding-related risks
  • proposed projects must be carried out in low- and lower-middle- income countries and areas in africa, latin america, the caribbean, south and south-east asia, and the middle east.
  • in asia, institutions in advanced economies and large emerging economies, including china and india, are not eligible as leads in the current call.
  • the call will fund projects that have partnerships between research organizations, policy-makers, the private sector, civil society organizations, and/or other key implementing partners, that are well-positioned to achieve intended development outcomes.
  • projects can be single- or multi-country focused.
  • institutions and consortia comprising more than one institution can apply. one partner must be designated as the lead institution, and the lead institutions should submit the application to idrc on behalf of the consortium.
  • the lead institution must be based in the country of research focus, or in one of the focus countries in the case of multi-country projects.
  • north-south partnerships are eligible, but the southern partner should be the lead. 
  • applicants can be involved in multiple proposals but can be lead in only one.
  • un, donor, and multi-lateral organizations are not eligible to apply. 
  • applications from individual persons will not be accepted.
how to apply: 

canada’s international development research centre (idrc) is pleased to announce a new funding opportunity, implemented through its sustainable inclusive economies division. this call for expressions of interest aims to advance the generation and use of context-specific evidence that can contribute to women’s economic empowerment in the global south in the context of responses in lower-income countries to the covid-19 pandemic and the growing climate crisis.

the call will support solutions-oriented, local research and evidence that help address the specific and systemic barriers women face during and following the covid-19 pandemic, and in accessing opportunities that arise in new low-carbon economic activities. the call will address new barriers that have arisen during the pandemic, the continued disproportionate burden of unpaid care work and gendered social norms, and ways to support and scale women-led initiatives that promote sustainable recovery.

the call will support projects with a clear plan for how the results of the research are to be used by policy-makers, private-sector actors, and women-led and other organizations who are well positioned to advance women’s economic empowerment at scale. proposed projects must take place, and be carried out, by organizations based in low- and lower-middle-income countries in africa, latin america, the caribbean, south and south-east asia, and the middle east.

the call will support collaborative projects involving research organizations, policy-makers, private-sector actors, non-profit and grassroot organizations, and/or other key actors, including in different countries.

this call for expressions of interest (eoi) invites qualifying organizations to submit a short proposal that follows the guidance in this document.

external deadline: 
tuesday, april 13, 2021
url: 

https://www.idrc.ca/en/funding/call-expressions-interest-womens-economic...

agency: 
international development research centre
funding source: 
external
funding level: 
research

investigation of the thermoregulatory implications of varying soft armour torso coverage during prolonged physical activity in a hot environment

how to apply: 

the following services of the contractor are required: to conduct an observational study of the thermoregulatory, cardiovascular, and perceptual implications of varying soft armour torso coverage during physical activity under controlled environmental conditions.

external deadline: 
monday, april 19, 2021
url: 

https://click.mailsender05.com/ct/3166/2208528/762166053/5d9a49a8e70ad67...

agency: 
canadian institute for military and veteran health research
funding source: 
external
funding level: 
research

defense health program department of defense gulf war illness research program funding opportunities for fiscal year 2021 (fy21)

how to apply: 

he fy21 defense appropriations act provides funding to the department of defense gulf war illness research program (gwirp) to support research addressing gulf war illness treatment, diagnosis and pathobiology underlying symptoms of disease.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

 

the fy21 gwirp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website.   

 

applications submitted to the fy21 gwirp must address one or more of the following overarching challenges:

 

  • treatments:  eliminate the health consequences associated with gulf war illness (gwi) and/or revolutionize treatment
  • diagnosis:  better define and diagnose gwi
  • subtyping:  distinguish subtypes to better target treatments; or monitor therapy; or identify severity of gwi; or why gwi is worse for some veterans than for others
  • determinants:  identify and validate determinants of gwi, latency, and impacts on organs and systems
  • consequences:  determine whether gwi alters risk for developing neurological conditions, cancers, or other serious conditions; or whether gwi alters outcomes of other infections/diseases
  • communicate & educate:  help veterans, their caregivers, and clinicians communicate effectively about gwi, its symptoms, and potential treatments

https://cdmrp.army.mil/funding/gwirp

 

idea award – preproposal due may 7, 2021

independent investigators at all academic levels

  • supports high-risk/high-reward research in the earliest stages of development that will contribute to markers or treatments for gulf war illness (gwi).
  • emphasis is on impact and innovation; applications must articulate how results will lead to a clinical impact for veterans with gwi, even if a clinical impact is not an immediate outcome.
  • preliminary data are not required.
  • clinical trials are not allowed.
  • submission of a pre-application is required; application submission is by invitation only.
  • biorepository contribution options:
  • supports additional costs associated with submission of samples and data to the gwirp-supported biorepository resource network
  • applicants must submit a biorepository contribution statement providing a detailed accounting of proposed costs and a commitment to work with the gwirp-supported biorepository resources network.
  • application to this option is not a requirement for idea award submission.
  • maximum funding of $200,000 for direct costs (plus indirect costs)
  • maximum funding of $220,000 for direct costs with the biorepository contribution option (plus indirect costs).
  • maximum period of performance is 2 years

 

research advancement award – preproposal due may 7, 2021

independent investigators at all academic levels

  • supports applied research in gwi aimed at continued expansion and validation of markers and treatments that are supported evidence in the gwi field. 
  • preliminary data in the field of gwi and other supporting information is required.
  • applications must articulate how results will lead to a clinical impact for veterans with gwi, even if a clinical impact is not an immediate outcome.
  • clinical trials are not allowed.
  • submission of a pre-application is required; application submission is by invitation only.
  • biorepository contribution option:
  • supports additional costs associated with submission of samples and data to the gwirp-supported biorepository resource network.
  • applicants must submit a biorepository contributions statement providing a detailed accounting of proposed costs and a commitment to work with the gwirp-supported biorepository resource network
  • application to this option is not a requirement for research advancement award submission.
  • maximum funding of $600,000 for direct costs (plus indirect costs)
  • maximum funding of $620,000 for direct costs with the biorepository contribution option (plus indirect costs)
  • maximum period of performance is 3 years

 

clinical evaluation award – preproposal due may 7, 2021

independent investigators at all academic levels

  • supports translation of validated gwi research, including qualified and replicated preclinical findings, to a gulf war veteran population.
  • statistically powered biomarker trials with the potential to validate use of biomarkers as clinical endpoints or proof-of-concept intervention trials (e.g., pilot, first in human, phase i-iia) are encouraged under this funding opportunity.
  • preliminary data are required.
  • funding for this award mechanism must support research in a gulf war veteran population.  proof of availability and access to necessary cohort(s) and/or critical regents must be provided.
  • submission of a pre-application is required application submission is by invitation only.
  • biorepository contribution option:
  • supports additional costs associated with submission of samples and data to the gwirp-supported biorepository resource network.
  • applicants must submit a biorepository contribution statement providing a detailed accounting of proposed costs and a commitment to work with the gwirp-supported biorepository resource network.
  • application to this option is not a requirement for clinical evaluation award submission.
  • clinical consortium collaboration option:
  • supports additional costs associated with collaboration with the gwirp-support gulf war illness clinical trials and interventions consortium (gwictic).
  • applicants must submit a clinical consortium collaboration statement providing a detailed accounting of proposed costs and clearly articulating the qualifications of the research team and institutions to participate as a new clinical research site in the consortium.
  • application to this option is not a requirement for clinical evaluation award submission.
  • pre-application is required; full application submission is by invitation only.
  • maximum funding of $1,500,000 for direct costs (plus indirect costs)
  • maximum funding of $1,520,000 for direct costs with the biorepository contribution option (plus indirect costs).
    • maximum funding of $1,700,000 for direct costs with the clinical consortium collaboration option (plus indirect costs)
    • maximum period of performance is 3 years

 

therapeutic/biomarker trial award – preproposal due may 7, 2021

independent investigators at all academic levels

  • supports large-scale, pivotal (phase iib or iii) trials that revolutionize the clinical management of gwi.
  • proposed research should lead to an approach that is fundamentally better than interventions already approved or in clinical development.
  • objective biomarkers to measure the biological effect of an investigational therapeutic or predictive/cohort-selective biomarkers that indicate whether a specific therapy will be effective in an individual gulf war veteran or gulf war veteran subgroup must be included in the trial design.
  • investigators must have experience in successfully leading large-scale projects and demonstrated the ability to implement a clinical project successfully.
  • funding must be used to support a clinical trial.
  • proposal submission is required: application submission is by invitation only.
  • biorepository contribution option:
  • supports additional costs associated with submission of samples and data to the gwirp-supported biorepository resource network
  • applicants must submit a biorepository contribution statement providing a detailed accounting of proposed costs and a commitment to work with the gwirp-supported biorepository resource network.
  • application to this option is not a requirement for therapeutic/biomarker trial award submission.
  • clinical consortium collaborative option:
  • supports additional costs associated with collaboration with the gwirp-supported gulf war illness clinical trials and interventions consortium (gwictic).
  • applicants must submit a clinical consortium collaborative statement providing a detailed accounting of proposed costs and clearly articulates the qualifications of the research team and institution to participate as a new clinical research site in the consortium.
  • application to this option is not a requirement for therapeutic/biomarker trial award submission.
    • maximum funding of $5,000,000 for direct costs (plus indirect costs)
    • maximum funding of $5,020,000 for direct costs with the biorepository contribution option (plus indirect costs).
    • maximum funding of $5,500,000 for direct costs with the clinical consortium collaboration option (plus indirect costs).
    • maximum period of performance is 3 years

 

new investigator award – preproposal due may 7, 2021

pis may apply under one of the following three eligibility categories:

 

transitioning postdoctoral fellow:  senior postdoctoral fellows with at least 3 years of postdoctoral training

early-career investigator:  independent investigators within 5 years of last training position

new gwi researcher:  established independent investigators who have received less than $300,000 in federally funded, non-mentored gwi research

  • encourages applications from early-stage and established investigators new to the field of gwi research.
  • previous experience in gwi research is not required; however, collaborations with experienced gwi researchers is strongly encouraged.
  • preliminary data are not required.
  • clinical trials are not allowed.
  • preproposal submission is required; application submission is by invitation only.
  • biorepository contribution option:
  • supports additional costs associated with submission of samples and data to the gwirp-supported biorepository resource network.
  • applicants must submit a biorepository contribution statement providing a detailed accounting of proposed costs and a commitment to work with the gwirp-supported biorepository resource network.
  • application to this option is not a requirement for new investigator award submission.
    • maximum funding of $500,000 for direct costs (plus indirect costs)
    • maximum funding of $520,000 for direct costs with the biorepository contribution option (plus indirect costs)
    • the maximum period of performance is 3 years

 

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the gwirp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

 

point of contact:

cdmrp help desk 
301-682-5507 
help@ebrap.org

 

external deadline: 
friday, may 7, 2021
url: 

https://cdmrp.army.mil/funding/gwirp

agency: 
department of defense
funding source: 
external
funding level: 
research

defense health program department of defense peer review medical research program funding opportunities for fiscal year 2021 (fy21)

how to apply: 

clinical trial award – preproposal due may 13, 2021

assistant professor level or above (or equivalent)

  • preproposal submission is required; application submission is by invitation only.
    • supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area(s) of interest.
    • proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
    • two options will be offered:

○       planning phase with clinical trial option: provides support to prepare and submit an investigational new drug/investigational device exemption (ind/ide) application to the u.s. food and drug administration (fda) and requires fda/regulatory approval or exemption to proceed before the clinical trial award is made.

○       clinical trial only option: provides support for the clinical trial. investigational new drug or investigational device exemption applications to the food and drug administration (fda), if needed, must be approved by the fda and included in the application submission.

clinical trial:

  • funding limit not defined; requested funding must be appropriate for the scope of work proposed
  • maximum period of performance is 4 years for the clinical trial
  • maximum of $500,000 for direct costs (plus indirect costs) for the planning phase option
  • maximum period of performance is 18 months for the planning phase option

planning phase with clinical trial option:

 

discovery award – letter of intent due april 29, 2021

postdoctoral fellow or clinical fellow (or equivalent) and above

  • supports the exploration of a highly innovative new concept or untested theory.
  • not intended to support the logical progression of an already established line of questioning.
  • reviewers will be blinded to the identity of the principal investigator (pi), collaborators, and their organization(s).
  • clinical trials will not be funded.
  • maximum of $200,000 for direct costs (plus indirect costs)
  • maximum period of performance is 2 years

 

focused program award – preproposal due may 13, 2021

full professor level or above (or equivalent)

  • preproposal submission is required; application submission is by invitation only.
  • supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal.
    • projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications.
    • projects may range from exploratory/hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question.
    • research team of highly qualified, multidisciplinary project leaders should be led by a pi with demonstrated success in directing large, focused projects.

 

 

  • maximum of $7.2 million for direct costs (plus indirect costs)
  • maximum period of performance is 4 years

 

investigator-initiated research award – preproposal due by april 28, 2021

assistant professor level or above (or equivalent)

  • preproposal submission is required; application submission is by invitation only.
  • supports research that will make an original and important contribution to the field of research or patient care in the topic area(s) of interest.
  • partnering pi option available.
  • clinical trials will not be funded.
  • maximum of $1.6 million for direct costs (plus indirect costs)
  • maximum of $2 million for direct costs (plus indirect costs) for applications including a partnering pi option
  • maximum period of performance is 4 years

 

technology/ therapeutic development award – preproposal due by april 28, 2021

assistant professor level or above (or equivalent)

  • preproposal submission is required; application submission is by invitation only.
    • supports the translation of promising preclinical findings into clinical applications for prevention, detection, diagnosis, treatment, or quality of life.
    • product-oriented (e.g., device, drug, clinical guidelines). the product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product.
    • new for fy21: two funding levels available, depending on the maturity of the product. the following are general descriptions, although not all-inclusive, of the scope of research projects that would be appropriate to propose under each funding level:

○       funding level 1: supports research that is supported by significant preliminary data but has not advanced to the level of clinical translation.

○       funding level 2: supports research that is in the final states of preclinical development with potential for near-term clinical development. applications must provide relevant data that support the rationale for the proposed study. funding level 2 recipients must submit or obtain an ind/ide application to the fda, or must transition the product to clinical practice, within the period of performance.

  • clinical trials will not be funded.
  • maximum of $2 million for direct costs (plus indirect costs)
  • maximum period of performance is 4 years
  • maximum of $4 million for direct costs (plus indirect costs)
  • maximum period of performance is 4 years

funding level 1:

funding level 2:

 

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website. the application package containing the required forms for each award mechanism will also be found on grants.gov. a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420.

 

 

 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org. for more information about the prmrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

 

point of contact:

cdmrp help desk 
 301-682-5507 
help@ebrap.org

external deadline: 
wednesday, april 28, 2021
url: 

https://cdmrp.army.mil/funding/prmrp

agency: 
department of defense
funding source: 
external
funding level: 
research

frontiers of knowledge awards

how to apply: 
the bbva foundation frontiers of knowledge awards recognize fundamental contributions in a broad array of areas of scientific knowledge, technology, humanities and artistic creation.
 

the disciplines and domains of the bbva foundation frontiers of knowledge awards are:

  1. basic sciences (physics, chemistry, mathematics)
  2. biology and biomedicine
  3. information and communication technologies
  4. ecology and conservation biology
  5. climate change
  6. economics, finance and management
  7. humanities and social sciences
  8. music and opera

the climate change award recognizes both research endeavors in confronting this challenge and impactful actions informed by the best science. in humanities and social sciences, the award will alternate annually between these two disciplinary domains, with this fourteenth edition dedicated to the social sciences. finally, the music and opera category encompasses composition, instrumental and vocal performance, musical and stage direction, and video art creation associated with musical or operatic works.

self-nomination is not permitted.

any scientific or cultural organization or institution can submit nominations, following their own internal procedures. among them:

  • scientific or artistic societies and organizations
  • national and regional academies of science or culture
  • public or private r&d centers
  • university schools, departments or institutes and research or teaching institutes
  • hospital departments and biomedical research centers
  • schools of music
  • orchestras, orchestra associations, opera theaters and opera associations
  • public agencies and supranational, national or regional organizations substantially engaged in analysis and/or activities relating to climate change
  • other scientific, cultural and environmental organizations

winners of the nobel prize in any of its categories are likewise eligible to nominate, as are past winners of the bbva foundation frontiers of knowledge awards.

the bbva foundation may also invite nominations from researchers and cultural creators that have made outstanding contributions in their respective fields, establishing consultative or advisory panels to this end.

the same organization, institution or individual nominator may put forward more than one candidate without limitation of number, but no candidate may be nominated in more than one award category.

if this award is of interest, please contact dr. batia stolar, associate vice-president, research & graduate studies, at avp.research@lakeheadu.ca for more information.

external deadline: 
wednesday, june 30, 2021
url: 

https://www.frontiersofknowledgeawards-fbbva.es/

award category: 
award
agency: 
bbva foundation
funding source: 
external
funding level: 
research

volvo environment prize

how to apply: 

laureates represent all fields of environmental and sustainability studies and initiatives. 

the prize is awarded by an independent foundation. a scientific committee does the initial screening and evaluation of candidates. internationally renowned scientists in the prize jury make the final selection of prize laureate. 

the prize is awarded annually and consists of a hand-crafted diploma, a glass sculpture and a cash award of sek 1.5 million (approximately eur 150,000 or usd 160,000). the award ceremony is held in stockholm in november  each year.

if this award is of interest, please contact dr. batia stolar, associate vice-president, research & graduate studies, at avp.research@lakeheadu.ca for more information.

external deadline: 
monday, january 10, 2022
url: 

https://www.environment-prize.com/the-prize/about-the-prize/

award category: 
award
agency: 
volvo environment prize foundation
funding source: 
external
funding level: 
research

volvo environment prize foundation

bbva foundation

community investment program grants fund

how to apply: 

cira’s community investment program grants fund innovative community internet projects to build a resilient, trusted and secure internet for all canadians.

in 2021, we’re especially looking for initiatives that benefit:

  • 世界杯2022赛程表淘汰赛 (kindergarten to grade 12 and post-secondary).
  • northern, rural and indigenous communities

 

external deadline: 
wednesday, april 14, 2021
url: 

https://www.cira.ca/improving-canadas-internet/grants#main-content

agency: 
canadian internet registration authority
funding source: 
external
funding level: 
research

pages